Mortality by heart failure and ischemic heart disease in Brazil from 1996 to 2011

Eduardo Nagib Gaui1, Gláucia Maria Moraes de Oliveira1, Carlos Henrique Klein2

  • 1Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Insights

Mortality from heart failure and ischemic heart diseases is declining in most of Brazil, with regional variations. Improvements in death record quality may explain the decrease in ill-defined cause deaths.

Area of Science:

  • Cardiovascular epidemiology
  • Public health surveillance
  • Geographic health disparities

Background:

  • Cardiovascular diseases represent the leading cause of death in Brazil.
  • Understanding mortality trends is crucial for public health interventions.

Purpose of the Study:

  • Analyze the trends in mortality from heart failure, ischemic heart diseases, and ill-defined causes in Brazil.
  • Examine these trends across Brazil's geoeconomic regions from 1996 to 2011.

Main Methods:

  • Utilized data from DATASUS and death declaration records.
  • Classified causes of death using ICD codes for ischemic heart diseases (I20-I25), heart failure (I50), and ill-defined causes (Chapter XIII).
  • Analyzed data by geoeconomic region (North, Northeast, Center-West, South, Southeast) between 1996 and 2011.

Main Results:

  • Heart failure mortality decreased nationwide, except in the North and Northeast.
  • Acute ischemic heart disease mortality rose in the North and Northeast, while decreasing in the South and Southeast.
  • Chronic ischemic heart disease mortality declined in most regions, with little change in the North and Northeast.
  • Ill-defined cause mortality was highest in the Northeast until 2005.

Conclusions:

  • Heart failure mortality shows a declining trend across Brazil's regions.
  • Ischemic heart disease mortality trends largely mirrored those of heart failure.
  • Decreasing ill-defined cause mortality suggests improved data quality.
  • Regional variations in acute ischemic heart disease mortality may be linked to changes in ill-defined cause reporting.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...